233 related articles for article (PubMed ID: 18154100)
1. [Secondary hyperparathyroidism: incidence, clinical presentations, treatment].
Samokhvalova NA; Romanchishen AF; Gerasimchuk RP; Grinev KM; Zemchenkov AIu
Vestn Khir Im I I Grek; 2007; 166(5):78-81. PubMed ID: 18154100
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. The need for better control of secondary hyperparathyroidism.
Locatelli F
Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V15-19. PubMed ID: 15284355
[TBL] [Abstract][Full Text] [Related]
4. Four gland parathyroidectomy without reimplantation in patients with chronic renal failure.
Saunders RN; Karoo R; Metcalfe MS; Nicholson ML
Postgrad Med J; 2005 Apr; 81(954):255-8. PubMed ID: 15811891
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
Sanadgol H; Bayani M; Mohammadi M; Bayani B; Mashhadi MA
Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
[TBL] [Abstract][Full Text] [Related]
6. Attainment of the Japanese Society for Dialysis Therapy guidelines for the management of secondary hyperparathyroidism in chronic hemodialysis patients in our clinic.
Sato Y; Eriguchi R; Umakoshi J; Kato M
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S48-53. PubMed ID: 17976086
[TBL] [Abstract][Full Text] [Related]
7. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid interventions for secondary hyperparathyroidism in hemodialyzed patients.
Onoda N; Kashiwagi T; Nakamura T; Niitsu Y; Omata M; Kurihara S
Ther Apher Dial; 2005 Aug; 9 Suppl 1():S11-5. PubMed ID: 16109135
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):48-52. PubMed ID: 15828906
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients.
Capuano A; Serio V; Pota A; Memoli B; Andreucci VE
J Nephrol; 2009; 22(1):59-68. PubMed ID: 19229819
[TBL] [Abstract][Full Text] [Related]
11. Prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin D supplementation.
Jean G; Vanel T; Terrat JC; Chazot C
Hemodial Int; 2010 Oct; 14(4):486-91. PubMed ID: 20955282
[TBL] [Abstract][Full Text] [Related]
12. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
Arenas MD; Alvarez-Ude F; Gil MT; Soriano A; Egea JJ; Millán I; Amoedo ML; Muray S; Carretón MA
Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
[TBL] [Abstract][Full Text] [Related]
13. Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.
Kazama JJ
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S44-7. PubMed ID: 17976085
[TBL] [Abstract][Full Text] [Related]
14. Intra-operative parathyroid hormone monitoring in secondary hyperparathyroidism: is it useful?
Roshan A; Kamath B; Roberts S; Atkin SL; England RJ
Clin Otolaryngol; 2006 Jun; 31(3):198-203. PubMed ID: 16759239
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome after total parathyroidectomy for the management of secondary hyperparathyroidism.
Stracke S; Keller F; Steinbach G; Henne-Bruns D; Wuerl P
Nephron Clin Pract; 2009; 111(2):c102-9. PubMed ID: 19142022
[TBL] [Abstract][Full Text] [Related]
16. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism.
Costa-Hong V; Jorgetti V; Gowdak LH; Moyses RM; Krieger EM; De Lima JJ
Surgery; 2007 Nov; 142(5):699-703. PubMed ID: 17981190
[TBL] [Abstract][Full Text] [Related]
17. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
[TBL] [Abstract][Full Text] [Related]
18. Quick PTH assay cannot predict incomplete parathyroidectomy in patients with renal hyperparathyroidism.
Kaczirek K; Riss P; Wunderer G; Prager G; Asari R; Scheuba C; Bieglmayer C; Niederle B
Surgery; 2005 Apr; 137(4):431-5. PubMed ID: 15800491
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome following total parathyroidectomy in patients with end-stage renal disease.
Kaye M; Rosenthall L; Hill RO; Tabah RJ
Clin Nephrol; 1993 Apr; 39(4):192-7. PubMed ID: 8491048
[TBL] [Abstract][Full Text] [Related]
20. Higher incidence of cholelithiasis in chronic renal failure patients with secondary hyperparathyroidism undergoing peritoneal dialysis.
Barut I; Tarhan OR; Baykal B; Demir M; Celikbas B
Ren Fail; 2007; 29(4):453-7. PubMed ID: 17497468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
